- Show all
- Abigail Coursolle
- Alejandra Pavisich
- Fabiola Carrión
- Amy Chen
- Corey Davis
- Andrew DiAntonio
- Elizabeth Edwards
- Candace Gibson
- Sarah Grusin
- Miriam Delaney Heard
- Hannah Eichner
- Héctor Hernández-Delgado
- Rachel Holtzman
- Priscilla Huang
- Alicia Emanuel
- Jennifer Lav
- Leonardo Cuello
- Kimberly Lewis
- David Machledt
- Elizabeth McCaman
- Ian McDonald
- Catherine McKee
- Joe McLean
- Maya Levin
- Michelle Lilienfeld
- Madeline Morcelle
- Kasey Nichols
- Hayley Penan
- Jane Perkins
- Alexis Robles-Fradet
- Susan Berke Fogel
- Sarah Somers
- Elizabeth G. Taylor
- Wayne Turner
- Mara Youdelman
- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- Show all
- 50th Anniversary
- Abortion
- Affordable Care Act
- Child and Adolescent Health
- CHIP
- Civil Procedure
- Civil Rights
- Coronavirus
- Cost-sharing
- Court Access
- Data Collection
- Defending Medicaid
- Demonstrations
- Disability Rights
- Doula Care
- Dual Eligible Beneficiaries
- Dually eligible
- Eligibility and Enrollment
- EPSDT
- Exchanges/Marketplaces
- Family Planning
- Federal and State Court Cases
- HCBS/LTSS
- Health Care Reform
- Health Care Refusals
- Health Disparities
- Health Reform
- HIV/AIDS and Sexual Health
- Home and Community Based Services
- Language Access
- LGBTQ Health
- Litigation
- Managed Care
- Medi-Cal
- Medicaid
- Mental Health
- Nondiscrimination
- Opioid Use Disorder
- Oral Health
- Pregnancy
- Prescription Drugs Marketplace
- Prescription Drugs Medicaid
- Privacy and Confidentiality
- Public Charge
- Public Health
- Reproductive Health
- Services
- Supreme Court
- Telehealth
- Waivers and Demonstrations
- Women's Health
- women's health
Archives
- December 21, 2018
Comments Urging HIV Prevention Drug be Designated an ACA “A” Recommended Service
Read morePeople who are at risk for HIV can prevent infection by taking a daily medication - Pre Exposure Prophylaxis (PrEP). However, many cannot access PrEP due to its high cost. The Affordable Care Act (ACA) recognizes that even small investments in preventive screenings and services can yield significant cost…
- December 21, 2018
National Health Law Program Priority Goals for Improving Health Care in California
Read moreIn a letter to California Governor-Elect Gavin Newsom, the National Health Law Program provides its "priority goals to improve health care in California" in 2019. "Your administration has an opportunity to further expand the coverage gains our state has made, while protecting individuals and families across the state from…
- December 18, 2018
Amicus Brief in Support of Maryland’s Anti-Price Gouging Law for Prescription Drugs
Read moreThe National Health Law Program filed an amicus brief with the United States Supreme Court asking it to review a 4th Circuit decision that struck down Maryland's anti-price gouging law for prescription drugs as unconstitutional. The brief focuses on the impact of high drug costs on low-income people and…
- December 18, 2018
Are Rights A Reality? Evaluating Federal Civil Rights Enforcement
Read moreThe National Health Law Program has urged the U.S. Commission on Civil Rights to investigate the "ways in which the Trump administration has actively worked to dismantle important federal civil rights laws that exist to protect the health rights of low-income people, people of color, LGBTQ people, immigrants, and…
- December 14, 2018
Comments to the FDA Urging Approval of Over the Counter Naloxone
Read moreThe National Health Law Program strongly urges the Food and Drug Administration (FDA) to initiate the process of moving at least one naloxone product from prescription to over the counter (OTC) status. Naloxone, a safe and effective medication, reverses opioid overdose if given in time, but is often not…
- December 14, 2018
Routes to Success for Medicaid Coverage of Doula Care
Read moreRacism and racial bias in health care have helped contribute to what is now coming to be understood as a national crisis of maternal deaths for women of color, in particular Black and Indigenous/U.S. Indian women. The statistics are shocking: Black women are three to four times as likely…
